Similar articles

• Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia.

  Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Kalambokis GN, et al. Liver Int. 2012 Mar;32(3):467-75. doi: 10.1111/j.1478-3231.2011.02650.x. Epub 2011 Sep 26. Liver Int. 2012. PMID: 22098272 Clinical Trial.
• Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?

  Savarino E, Assandri L, Giannini EG, Savarino V. Savarino E, et al. Am J Gastroenterol. 2011 Jun;106(6):1171-2; author reply 1172. doi: 10.1038/ajg.2011.106. Am J Gastroenterol. 2011. PMID: 21637276 Clinical Trial. No abstract available.
• Rifaximin treatment in hepatic encephalopathy.

  Xue T, Qiu JH, Qiao L. Xue T, et al. N Engl J Med. 2010 Jun 24;362(25):2424; author reply 2424-5. N Engl J Med. 2010. PMID: 20578275 No abstract available.
• Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.

  Ponziani FR, Gerardi V, Pecere S, D'Aversa F, Lopetuso L, Zocco MA, Pompili M, Gasbarrini A. Ponziani FR, et al. World J Gastroenterol. 2015 Nov 21;21(43):12322-33. doi: 10.3748/wjg.v21.i43.12322. World J Gastroenterol. 2015. PMID: 26604640 Free PMC article. Review.
• [Rifaximin].

  Gobernado M, Ponce J. Gobernado M, et al. Rev Esp Quimioter. 2004 Jun;17(2):141-53. Rev Esp Quimioter. 2004. PMID: 15470508 Review. Spanish. No abstract available.